Erlotinib Active Not Recruiting Phase 1 Trials for Stage IV Pancreatic Cancer AJCC v6 and v7 / Adult Solid Neoplasm / Stage IV Pancreatic Cancer / Pancreatic Ductal Adenocarcinoma / Pancreatic Acinar Cell Carcinoma / Recurrent Pancreatic Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00878163GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
NCT00045201Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors